Biotech · Public company · Fremont, CA, US

Ardelyx, Inc.

Ticker ARDX · SEC CIK 0001437402

Track this companyFree. Adds Ardelyx, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials234 recruiting or active

Pipeline programs20From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline20

AZD1722Phase 3 · Constipation Predominant Irritable Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Phosphate Binder AgentsPhase 3 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
Sevelamer CarbonatePhase 3 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
TenapanorPhase 3 · Constipation Predominant Irritable Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
TenapanorPhase 3 · Irritable Bowel Syndrome With Constipation (IBS-C)ClinicalTrials.gov · fetched Nov 12, 2026
TenapanorPhase 3 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
Tenapanor 25 mg bidPhase 3 · Irritable Bowel Syndrome With Constipation (IBS-C)ClinicalTrials.gov · fetched Nov 12, 2026
Tenapanor 25 mg BIDPhase 3 · Chronic Idiopathic Constipation (CIC)ClinicalTrials.gov · fetched Nov 12, 2026
Tenapanor 5 mg BIDPhase 3 · Chronic Idiopathic Constipation (CIC)ClinicalTrials.gov · fetched Nov 12, 2026
Tenapanor 50 MGPhase 3 · Irritable Bowel Syndrome With Constipation (IBS-C)ClinicalTrials.gov · fetched Nov 12, 2026
Tenapanor 50 mg BIDPhase 3 · Chronic Idiopathic Constipation (CIC)ClinicalTrials.gov · fetched Nov 12, 2026
AZD1722Phase 2 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
AZD1722Phase 2 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
AZD1722 (in-patient)Phase 2 · End Stage Renal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
AZD1722 (out-patient)Phase 2 · End Stage Renal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
RDX013Phase 2 · HyperkalemiaClinicalTrials.gov · fetched Nov 12, 2026
RDX227675Phase 2 · HyperkalemiaClinicalTrials.gov · fetched Nov 12, 2026
RDX5791Phase 2 · Constipation Predominant Irritable Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
TenapanorPhase 1 · LactationClinicalTrials.gov · fetched Nov 12, 2026
TenapanorChronic Kidney Disease Requiring Chronic DialysisClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials23

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in AdultsPHASE3 · RECRUITING · started Jan 13, 2026ClinicalTrials.gov NCT07382167 · fetched Nov 12, 2026
Assessing Tenapanor as a Treatment of CF-related Constipation.PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 1, 2025ClinicalTrials.gov NCT06810167 · fetched Nov 12, 2026
Tenapanor in Synucleinopathy-Related ConstipationPHASE2 · RECRUITING · started Jan 1, 2025ClinicalTrials.gov NCT06460038 · fetched Nov 12, 2026
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 YrsPHASE2 · COMPLETED · started Jul 24, 2024ClinicalTrials.gov NCT06553547 · fetched Nov 12, 2026
Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With ConstipationPHASE4 · COMPLETED · started Feb 6, 2024ClinicalTrials.gov NCT05995899 · fetched Nov 12, 2026
An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating FemalesPHASE1 · COMPLETED · started Nov 27, 2023ClinicalTrials.gov NCT06203444 · fetched Nov 12, 2026
Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-CPHASE3 · ENROLLING_BY_INVITATION · started Feb 17, 2023ClinicalTrials.gov NCT05905926 · fetched Nov 12, 2026
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 YearsPHASE3 · COMPLETED · started Nov 15, 2022ClinicalTrials.gov NCT05643534 · fetched Nov 12, 2026
A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of HyperkalemiaPHASE2 · COMPLETED · started Jan 11, 2021ClinicalTrials.gov NCT04780841 · fetched Nov 12, 2026
Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of HyperphosphatemiaPHASE4 · COMPLETED · started Nov 20, 2020ClinicalTrials.gov NCT04549597 · fetched Nov 12, 2026
A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HPPHASE4 · COMPLETED · started Jun 15, 2019ClinicalTrials.gov NCT03988920 · fetched Nov 12, 2026
Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder TherapyPHASE2_PHASE3 · COMPLETED · started Feb 28, 2019ClinicalTrials.gov NCT03824587 · fetched Nov 12, 2026
A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on DialysisPHASE3 · COMPLETED · started Jan 8, 2018ClinicalTrials.gov NCT03427125 · fetched Nov 12, 2026
A Study Evaluating the Onset-of-Action, Safety, and Efficacy of RDX227675 for the Treatment of HyperkalemiaPHASE2 · TERMINATED · started Jan 1, 2017ClinicalTrials.gov NCT03018067 · fetched Nov 12, 2026
A Long-Term Safety Study of Tenapanor for the Treatment of IBS-CPHASE3 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02727751 · fetched Nov 12, 2026
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)PHASE3 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02675998 · fetched Nov 12, 2026
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-CPHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02686138 · fetched Nov 12, 2026
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-CPHASE3 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02621892 · fetched Nov 12, 2026
Dose Finding Study to Treat High Phosphate Levels in the Blood.PHASE2 · COMPLETED · started Mar 1, 2014ClinicalTrials.gov NCT02081534 · fetched Nov 12, 2026
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)PHASE2_PHASE3 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01923428 · fetched Nov 12, 2026
A Study in CKD Patients With Type 2 Diabetes Mellitus and AlbuminuriaPHASE2 · COMPLETED · started May 1, 2013ClinicalTrials.gov NCT01847092 · fetched Nov 12, 2026
Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on HemodialysisPHASE2 · COMPLETED · started Jan 1, 2013ClinicalTrials.gov NCT01764854 · fetched Nov 12, 2026
A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)PHASE2 · COMPLETED · started May 1, 2011ClinicalTrials.gov NCT01340053 · fetched Nov 12, 2026

SEC filings12

10-Q · 10-QSEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 17, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jul 2, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jun 17, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
10-K · 10-KSEC EDGAR · filed Feb 19, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Feb 19, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jan 8, 2026 · fetched Nov 12, 2026